Thomson offers Filter Plates in configurations optimized for analytical sample clarification (PPE, PVDF & PTFE membranes).
Membrane | Pore Size | Referance | |
---|---|---|---|
5-Fluorouracil | PTFE | 0.2μm | |
(18F) Fluoromisondazole, Misiomidazole | PVDF | 0.2μm | |
Alpha1-Proteinase Inhibitor (Human) | PVDF | .45μm | |
Amphotericin B for Injection USP | PVDF | .45μm | |
Azathioprine | PVDF | .45μm | |
Bleomycin Sulfate | PTFE | 0.2μm | |
Cetirizine | PVDF | .45μm | |
Cisplatin, Cisplatin Injection | PTFE | 0.2μm | |
Cyclosporine A | PVDF | 0.2μm | |
Cytarabine | PTFE | 0.2μm | |
Daunorubicin | PTFE | 0.2μm | |
Diclofenac | PVDF | .45μm | |
Ethionamide | PTFE | 0.2μm | |
Factor IX Complex Heat-Treated | PVDF | .45μm | |
Gatifloxacin | PVDF | .45μm | |
Ibuprofen | PVDF | .45μm | |
Iosniazid | PTFE | 0.2μm | |
isonicotinic acid | PTFE | 0.2μm | |
Las 35917 | PVDF | .45μm | |
Levofloxacin | PVDF | .45μm | |
Lomefloxacin | PVDF | .45μm | |
Methyl Gag; NSC-32946 | PTFE | 0.2μm | |
Mitomycin | PTFE | 0.2μm | |
Morphazinamide | PTFE | 0.2μm | |
Nicotinic acid | PTFE | 0.2μm | |
Paclitaxel | PVDF | 0.2μm | |
p-Aminobenzoic acid (PABA) | PVDF | .45μm | |
p-aminosalicylic acid | PTFE | 0.2μm | |
Pefloxacin | PVDF | .45μm | |
Pentoxifylline (PTX) | PVDF | 0.2μm | |
Phenytoin | PVDF | .45μm | |
Pyrazinamide | PTFE | 0.2μm | |
Pyrimethamine | PVDF | .45μm | |
Rifampicin | PVDF | .45μm | |
Sabeluzole | PVDF | .45μm | |
Streptokinase | PVDF | .45μm | |
Sulfadozine | PVDF | .45μm | |
Thiotepa Parenteral Sterile | PTFE | 0.2μm | |
Tobramycin Vincristine Sulfate | PTFE | 0.2μm | |
Triazinate; NSC-139105 | PTFE | 0.2μm | |
Tropicamide | PVDF | .45μm | |
Vinblastine Sulfate | PTFE | 0.2μm |
Referance:
- Santini, A. O. et al. (2004). p-Aminobenzoate ion determination in pharmaceutical formulations by using a potentiometric sensor immobilized in a graphite matrix. Talanta 63:833-838.
- Bosanquet, A.G. (1985) Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. General considerations, the nitrosoureas and alkylating agents. Cancer Chemother. Pharmacol. 14:83-95
- Capello, B. et al. (2001) Solubilization of tropicamide by hydroxypropyl-[beta]-cyclodextrin and water-soluable polymers: in vitro/in vivo studies. Int. J. Pharm.213:75-81.
- Butler, L.D., et al (1980). Effect of inline filtration on the potency of low-dose drugs. Am. J. Hosp. Pharm. 37:935-941.
- Chang, C.W., et al.(2007). A robotic synthesis of [18F]fluoromisonidazole([18F]FMISO), Applied Radiation and Isotopes, In Press, Accepted Manuscript, Available online 6 February.
- Fagny, C., et al. (2002). Ribonucleotide reductase and thymidine phosphorylation: two potential targets of azodicarbonamide. Biochem. Pharmacol. 64: 451-456.
- kiesewetter, et al. (2003). Fluoro-, bromo-, iodopaclitaxel derivatives: synthesis and biological evaluation. Nuclear Medicine and Biology. 30: 11-24.
- Elenbaas, J.K., et al. (1985). Effect of inline filtration on tobramycin delivery. Drug Intell. Clin. Pharm. 19: 122-125.
- Ennis, C.E., et al. (1983) In vitro study of inline filtration of medications commonly administered to pediatric cancer patients. J. Parenter Enter.Nutr. 7: 156-158.
- Lallemand, et. al. (2005) A novel water-soluble cyclosporine A prodrug: Ocular tolerance and in vivo kinetics. Int.J.Pharm. 295: 7-14.
- Verreck, G., et al. (2005). Preparation and physicochemical characterization of biodegradable nerve guides containing the nerve growth agent sabeluzole. Biomaterials 26: 1307-1315.
- Flaten, G.E., et al. (2006) Drug permeability across a phospholipid vesicle based barrier. A novel approach for studying passive diffusion. European Journal of Pharmaceutical Sciences 27: 80-90.
- Grant, A.M.(1987). Personal communication.
- Huber, R.C. and Riffkin, C. (1975) Inline final filters for removing particles from amphotericin B infusions. Am.J.Hosp.Pharm. 32: 173-176.
- Toro, I. et al. (2004). Development and validation of a capillary electrophoresis method with ultraviolet detection for the determination of the related substances in a pharmaceutical compound. J. Chromatogr. A 1043: 303-315
- Calleja, I. et al. (2004). High-performance liquid-chromatographic determination of rifampicin in plasma and tissues. J. Chromatogr. 1031: 289-294.
- Gennaro, M.C., et al. (2001) Ion interaction reagent reversed-phase high-performance liquid chromatography determination of anti-tuberculosis drugs and metabolites in biological fluids. J. Chromatogr. B 754: 477-486.
- Kanke, M., et al. (1983). Binding of selected drugs to a “treated” inline filter. Am. J. Hosp.Pharm. 40: 1323-1328.
- Khue, N. V., and Jung, L. (1985). Study of the retention of child-dose drugs on cellulose ester membranes during inline intravenous filtration. S-T-P Pharma. 1: 201-207.
- Boca, M.B., et al. (2005), A validated HPLC method for determining residues of a dual active ingredient anti-malarial drug on manufacturing equipment surfaces. J. Pharm. Biomed.Anal. 37:461-468.
- Maddus, M.S. , and Barrierre, S.L. (1980). A review of complications of amphotericin B therapy; recommendations for prevention and management. Drug Intell. Clin. Pharm. 14: 177-181.
- Ines, M., et al. (2006). Quantitative determination of gatifloxacin, levofloxacin, lomefloxacin and pefloxacin fluoroquinolonic antibodies in pharmaceutical preparations by high-performance liquid chromatography. J. Pharm.Biomed.Anal. 40: 179-184.
- Fantin, M., et al. (2006). Pentoxifylline and its major oxidative metabolites exhibit different pharmacological properties. European Journal of Pharmacology 535: 301-309.
- McEvoy, G. K. (Ed.) . (1991) American hospital formulary service drug information 91. American Society of Hospital Pharmacists.
- Ober, M.D. et al. (2006), Measurement of the Actual Dose of Triamcinolone Acetonide Delivered by Common Techniques of Intravitreal Injection. American Journal of Ophthalmology 142: 597-600.e1.
- Lofwall, M. R. ,et al. (2006). Cognitive and Subjective Acute Dose Effects of Intramuscular Ketamine in Healthy Adults. Experimental and Clinical Psychopharmacology 14: 439-449.
- Kato, M., et al. (2005) Examination of meningocele induced by the antitumor agent DE-310 in rat fetuses. Reproductive Toxicology 20: 495-502.28. Miles Pharm.
- Langer, O., et al. (2003). Synthesis of fluorine-18-labeled ciprofloxacin for PET studies in humans. Nuclear Medicine and Biology 30: 285-291.
- Pavlik, E. J., et al. (198e). Properties of anticancer agents relevant to in vitro determinations of human tumor cell sensitivity. Cancer Chemother. Pharmacol. 11: 8-15.
- Pavlik, E.J., et al. (1982) Sensitivity to anticancer agents in vitro: standardizing the cytotoxic response and characterizing the sensitivities of a reference cell line. Gynecol. Oncol. 14: 243-261.
- Oradell, N.J., 1991). Physicians' Desk Reference. 45th edition.
- Rusmin, S., et al. (1977). Effect of inline filtration on the potency of drugs administered intravenously. Am.J. Hosp. Pharm. 34: 1071-1074.
- Rudaz, S., et al. (2003). Veuthey, Development and validation of a heart-cutting liquid chromatography-mass spectrometry method for the determination of process-related substances in cetirizine tablets. Analytica Chimica Acta 492: 271-282.
- Fazio, T.T., et al. (2007) Quantitative determination and sampling of azathioprine residues for cleaning validation in production area. J. Pharm. Biomed,Anal. 43: 1495-1498.
- Thompson, D. F., et al. (1984). Effect of inline filtration on pediatric doses of gentamicin and tobramycin. Infusion 8: 31-32.
- Tipple, M. et al. (1977). Availability of active amphotericin B after filtration through membrane filters. Am. Rev. Resp.Dis 115: 879-881.